News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Silva Francisco
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/04/2023 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 747 shares
@ $3.56, valued at
$2.7k
|
|
03/22/2023 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Paid exercise price by delivering 6,729 shares
@ $2.92, valued at
$19.6k
|
|
02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/21/2022 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 943 shares
@ $2.6162, valued at
$2.5k
|
|
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2022 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 725 shares
@ $3.3884, valued at
$2.5k
|
|
10/12/2022 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 806 shares
@ $3.6886, valued at
$3k
|
|
09/09/2022 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Sold 3,958 shares
@ $3.388, valued at
$13.4k
Bought 2,600 shares
@ $3.35, valued at
$8.7k
Bought 2,816 shares
@ $3.213, valued at
$9k
Bought 307 shares
@ $3.319, valued at
$1k
|
|
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2022 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 12,438 shares
@ $0 |
|
11/22/2021 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 4,000 shares
@ $6.6565, valued at
$26.6k
|
|
11/16/2021 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 3,826 shares
@ $6.83, valued at
$26.1k
Bought 4,000 shares
@ $6.625, valued at
$26.5k
|
|
11/08/2021 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Disposed/sold 293,479 options
@ $47.6, valued at
$14M
Granted 293,479 options
@ $13.5, valued at
$4M
Granted 42,059 options
@ $13.5, valued at
$567.8k
|
|
03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/24/2020 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Acquired 8,375,671 shares
@ $0 |
|
09/06/2019 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 2,500 shares
@ $0.2355, valued at
$588.8 Bought 18,455 shares
@ $0.24, valued at
$4.4k
|
|
09/03/2019 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 2,500 shares
@ $0.26, valued at
$650 Bought 5,000 shares
@ $0.2799, valued at
$1.4k
Bought 10,500 shares
@ $0.28, valued at
$2.9k
|
|
08/28/2019 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 3,500 shares
@ $0.29, valued at
$1k
Bought 4,000 shares
@ $0.25, valued at
$1k
|
|
08/23/2019 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 8,446 shares
@ $0.2304, valued at
$1.9k
Bought 8,928 shares
@ $0.28, valued at
$2.5k
|
|
03/26/2019 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Disposed/sold 4,000 options
@ $4.7, valued at
$18.8k
Granted 4,000 options
@ $0.75, valued at
$3k
Disposed/sold 150 options
@ $4.7, valued at
$705 Granted 150 options
@ $0.75, valued at
$112.5 Disposed/sold 1,000 options
@ $4.7, valued at
$4.7k
Granted 1,000 options
@ $0.75, valued at
$750 Disposed/sold 2,000 options
@ $4.7, valued at
$9.4k
Granted 2,000 options
@ $0.75, valued at
$1.5k
Disposed/sold 5,500 options
@ $4.7, valued at
$25.9k
Granted 5,500 options
@ $0.75, valued at
$4.1k
Disposed/sold 5,000 options
@ $4.7, valued at
$23.5k
|
|
10/31/2018 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 100,000 options
@ $1.23, valued at
$123k
|
|
07/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2017 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Bought 50 shares
@ $10.4, valued at
$520 Bought 100 shares
@ $10.4, valued at
$1k
Bought 20 shares
@ $7.6, valued at
$152 Bought 25 shares
@ $7.6, valued at
$190 Bought 2,250 shares
@ $4.25, valued at
$9.6k
Bought 1,800 shares
@ $4.38, valued at
$7.9k
|
|
02/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/23/2015 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 25,000 options
@ $7, valued at
$175k
|
|
10/27/2014 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 750,000 options
@ $0.33, valued at
$247.5k
|
|
04/16/2014 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 40,000 options
@ $1.4, valued at
$56k
|
|
03/14/2014 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 40,000 options
@ $0.53, valued at
$21.2k
|
|
02/20/2014 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns:
| Granted 250,000 options
@ $0.65, valued at
$162.5k
|
|
10/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|